Opin vísindi

Browsing by Author "Deurinck, Mark"

Browsing by Author "Deurinck, Mark"

Sort by: Order: Results:

  • Curcic, Jelena; Vallejo, Vanessa; Sorinas, Jennifer; Sverdlov, Oleksandr; Praestgaard, Jens; Piksa, Mateusz; Deurinck, Mark; Erdemli, Gul; Bügler, Maximilian; Tarnanas, Ioannis; Taptiklis, Nick; Cormack, Francesca; Anker, Rebekka; Massé, Fabien; Souillard-Mandar, William; Intrator, Nathan; Molcho, Lior; Madero, Erica; Bott, Nicholas; Chambers, Mieko; Tamory, Josef; Shulz, Matias; Fernandez, Gerardo; Simpson, William; Robin, Jessica; Snædal, Jón G; Cha, Jang-Ho; Hannesdottir, Kristin (2022-08-10)
    BACKGROUND: More sensitive and less burdensome efficacy end points are urgently needed to improve the effectiveness of clinical drug development for Alzheimer disease (AD). Although conventional end points lack sensitivity, digital technologies hold ...